Geisel Researchers Awarded $5.3 Million for Opioid Research

The research team will focus on treatment of opioid-use disorder among pregnant women.

Read the full story, published by the Geisel School of Medicine.

lord-goodman-2-450x360.jpg

Sarah Lord and Daisy Goodman
Geisel’s Sarah Lord, left, and Daisy Goodman will lead the research team. (Photo by Rob Strong ’04)

A Geisel research team has been approved for a $5.3 million funding award from the Patient-Centered Outcomes Research Institute (PCORI)—to conduct comparative clinical effectiveness research on medication-assisted treatment for pregnant women with opioid use disorders.

The team will be led by Sarah Lord, an assistant professor of psychiatry and of pediatrics, and Daisy Goodman, a clinical assistant professor of obstetrics and gynecology and of community and family medicine.

The award is one of nine new comparative clinical effectiveness research awards being offered by PCORI (with a total of $74 million in funding) to support research on a range of conditions that impose high burdens on patients, caregivers, and the healthcare system.

“I’m very excited that Sarah and Daisy have received this award from PCORI to address this significant public health crisis,” says Duane Compton, dean of the medical school. “Their innovative research will enhance the excellent work that is underway between Geisel and Dartmouth-Hitchcock investigators and their community partners to find the most effective ways to treat opioid addiction for both mothers and their infant children.”